Landscape Capital Management’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Landscape Capital Management's RNAM Position: Q1 2026 in Review
Landscape Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 32,493 shares — an estimated $2.34M sold.
Landscape Capital Management first reported a position in RNAM in Q4 2022 and held it in 3 quarters. The position peaked at $2.34M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Landscape Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Landscape Capital Management sold 32,493 Avidity Biosciences shares in Q1 2026, an estimated $2.34M.
- Landscape Capital Management first reported a position in Avidity Biosciences in Q4 2022 and held it in 3 quarters.
- Landscape Capital Management's Avidity Biosciences position peaked at $2.34M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.